(Takeda cTTP-2) A Phase 3b, open-label, continuation study of prophylactic and on-demand treatment of cTTP with TAK-755 (rADAMTS-13, also known as BAX 930/SHP655)
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
Takeda Development Center Americas, Inc
Start Date
January 5, 2022
End Date
May 31, 2025
Administered By
Medicine, Hematology
Awarded By
Takeda Development Center Americas, Inc
Start Date
January 5, 2022
End Date
May 31, 2025